184 related articles for article (PubMed ID: 38498052)
1. Investigating Nonspecific Effects of the Live-Attenuated Japanese Encephalitis Vaccine on Lower Respiratory Tract Infections in Children Aged 25-35 Months: Retrospective Cohort Study.
Zhan S; Lin H; Yang Y; Chen T; Mao S; Fu C
JMIR Public Health Surveill; 2024 Mar; 10():e53040. PubMed ID: 38498052
[TBL] [Abstract][Full Text] [Related]
2. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
3. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.
Wang SY; Cheng XH; Li JX; Li XY; Zhu FC; Liu P
Hum Vaccin Immunother; 2015; 11(6):1418-25. PubMed ID: 25915588
[TBL] [Abstract][Full Text] [Related]
4. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013.
Wu W; Liu D; Li K; Nuorti JP; Nohynek HM; Xu D; Ye J; Zheng J; Wang H
Vaccine; 2017 Jun; 35(29):3666-3671. PubMed ID: 28552510
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
[TBL] [Abstract][Full Text] [Related]
6. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
Ginsburg AS; Meghani A; Halstead SB; Yaich M
Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
9. Current recommendations for the Japanese encephalitis vaccine.
Chen HL; Chang JK; Tang RB
J Chin Med Assoc; 2015 May; 78(5):271-5. PubMed ID: 25841620
[TBL] [Abstract][Full Text] [Related]
10. Allergic reactions to Japanese encephalitis vaccine.
Plesner AM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
[TBL] [Abstract][Full Text] [Related]
11. Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine.
Bouckenooghe A; Bailleux F; Feroldi E
Hum Vaccin Immunother; 2019; 15(1):72-79. PubMed ID: 30230947
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study.
Bista MB; Banerjee MK; Shin SH; Tandan JB; Kim MH; Sohn YM; Ohrr HC; Tang JL; Halstead SB
Lancet; 2001 Sep; 358(9284):791-5. PubMed ID: 11564484
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.
Wijesinghe PR; Abeysinghe MRN; Yoksan S; Yao Y; Zhou B; Zhang L; Fleming JA; Marfin AA; Victor JC
Vaccine; 2016 Nov; 34(48):5923-5928. PubMed ID: 27773472
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010-2022.
Hsu JY; Hung CC; Tsou TP; Chen WC
PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011421. PubMed ID: 37782654
[TBL] [Abstract][Full Text] [Related]
15. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
16. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815
[TBL] [Abstract][Full Text] [Related]
17. Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
Turtle L; Tatullo F; Bali T; Ravi V; Soni M; Chan S; Chib S; Venkataswamy MM; Fadnis P; Yaïch M; Fernandez S; Klenerman P; Satchidanandam V; Solomon T
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005263. PubMed ID: 28135273
[TBL] [Abstract][Full Text] [Related]
18. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
19. [Advances in research of interchangeable immunization with live attenuated Japanese encephalitis vaccines and inactivated vaccines].
Deng X; He HQ; Zhou Y; Yan R; Tang XW; Zhu Y; Xu XP; Lyu HK
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):554-560. PubMed ID: 35644967
[TBL] [Abstract][Full Text] [Related]
20. Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.
Chotpitayasunondh T; Pruekprasert P; Puthanakit T; Pancharoen C; Tangsathapornpong A; Oberdorfer P; Kosalaraksa P; Prommalikit O; Tangkittithaworn S; Kerdpanich P; Techasaensiri C; Korejwo J; Chuenkitmongkol S; Houillon G
Vaccine; 2017 Jan; 35(2):299-304. PubMed ID: 27903416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
